The evaluation of sperm DNA integrity is recommended in the sixth edition of the 2021 World Health Organization guidelines. Oxidative stress has been identified as a crucial factor leading to genome decay, lipid peroxidation, and nucleoprotein oxidation. This double-blind, placebo-controlled clinical trial aimed to assess the effect of oral antioxidant treatment (Fertilis), which contains L-carnitine and some micronutrients, in the improvement of conventional sperm parameters, sperm DNA integrity and in vitro fertilization/intracytoplasmic sperm injection (IVF/ICSI) outcomes.

MédiS, a major player in the Tunisian pharmaceutical industry, announces the launch of the first biosimilar of Glargine insulin for diabetes treatment on February 18, 2022, following approval from the Ministry of Health.

This biosimilar marks a significant milestone as the first of its kind in Tunisia, Africa, and the Arab world to comply with existing legislation and adhere to international manufacturing standards at every stage of protocols and procedures.

Dear Sisters and Brothers,

In 2023, MédiS Laboratories is pleased to invite you to participate in the Prix MédiS for the Best Orthopedic Thesis in its third edition. We are eagerly anticipating your submissions, adhering to the general terms outlined in the Prix MédiS Charter, before May 10, 2023.